Medicare Enrolled

Dr. Daniel Groblewski, MD

Neurology · Jacksonville, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3627 UNIVERSITY BLVD S, Jacksonville, FL 32216
9043964666
In practice since 2006 (19 years)
NPI: 1821179888 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Groblewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Groblewski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Groblewski

Dr. Daniel Groblewski is a neurology in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Groblewski performed 1,149 Medicare services across 855 unique beneficiaries.

Between the years covered by Open Payments, Dr. Groblewski received a total of $12,366 from 65 pharmaceutical and/or device companies across 776 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Groblewski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 28% volume in FL$ $12,366 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,149
Medicare services
Top 28% in FL for neurology
855
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~60 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)385$94$260
Initial hospital admission, high complexity193$137$432
Office visit, established patient (20-29 min)117$64$185
Measurement of brain wave activity (eeg), awake and drowsy100$43$165
Hospital follow-up visit, moderate complexity99$63$153
Hospital follow-up visit, high complexity87$94$219
Hospital follow-up visit, low complexity84$39$88
New patient office visit (45-59 min)70$124$339
Measurement of brain wave activity (eeg), digital analysis14$78$1,606
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,366
Total received (2018-2024)
Avg $1,767/year across 7 years
Top 24% in FL for neurology
65
Companies
776
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,173 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$216
2023
$646
2022
$2,253
2021
$2,197
2020
$2,412
2019
$2,427
2018
$2,215

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$944
Teva Pharmaceuticals USA, Inc.
$939
EMD Serono, Inc.
$912
US WorldMeds, LLC
$897
Biogen, Inc.
$748
Supernus Pharmaceuticals, Inc.
$611
Eisai Inc.
$600
Kyowa Kirin, Inc.
$488
Adamas Pharmaceuticals, Inc.
$470
Alexion Pharmaceuticals, Inc.
$466
ABBVIE INC.
$464
Neurocrine Biosciences, Inc.
$437
SK Life Science, Inc.
$347
EISAI INC.
$326
Novartis Pharmaceuticals Corporation
$304
Lilly USA, LLC
$282
AbbVie Inc.
$269
Lundbeck LLC
$222
Allergan, Inc.
$222
Sunovion Pharmaceuticals Inc.
$164
Allergan Inc.
$161
GENZYME CORPORATION
$161
Endo Pharmaceuticals Inc.
$140
Neurelis, Inc.
$124
UCB, Inc.
$105
Promius Pharma LLC
$92
Amneal Pharmaceuticals LLC
$88
Janssen Pharmaceuticals, Inc
$80
Genentech USA, Inc.
$76
ARBOR PHARMACEUTICALS, INC.
$74
Biohaven Pharmaceutical Holding Company Ltd.
$73
Mitsubishi Tanabe Pharma America, Inc.
$67
Biohaven Pharmaceuticals, Inc.
$61
Upsher-Smith Laboratories LLC
$61
ACADIA Pharmaceuticals Inc
$56
CSL Behring
$46
Celgene Corporation
$44
Almatica Pharma LLC
$42
Avion Pharmaceuticals
$41
Grifols USA, LLC
$40
Flowonix Medical Incorporated
$39
LivaNova USA, Inc.
$39
Egalet US Inc
$38
Acorda Therapeutics, Inc
$38
Otsuka America Pharmaceutical, Inc.
$37
Mallinckrodt LLC
$36
Mallinckrodt Enterprises LLC
$35
Avanir Pharmaceuticals, Inc.
$32
Arbor Pharmaceuticals, Inc.
$32
MITSUBISHI TANABE PHARMA AMERICA, INC.
$30
Impax Laboratories, Inc.
$27
TerSera Therapeutics LLC
$23
CATALYST PHARMACEUTICALS, INC.
$22
Abbott Laboratories
$21
Axsome Therapeutics, Inc.
$21
ASSERTIO THERAPEUTICS, INC.
$21
Ceribell, Inc.
$18
Corium, LLC
$18
PFIZER INC.
$17
JAZZ PHARMACEUTICALS INC.
$15
Vertical Pharmaceuticals, LLC
$14
Zyla Life Sciences
$13
MDD US Operations, LLC
$12
Alnylam Pharmaceuticals Inc.
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 22.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BELSOMRA · BOTOX · BOTOX - SPASTICITY · BOTOX THERAPEUTIC · Briviact · COPAXONE · Cambia · Cenobamate · Ceribell Rapid Response EEG · Dayvigo · Dhivy · EMGALITY · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NASCOBAL · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONPATTRO · OSMOLEX ER · Ongentys · PANZYGA · PRIALT · Ponvory · Prometra II · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SUNOSI · Soliris · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · Xadago · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,076 per 100 Medicare services performed
Looking for a neurology in Jacksonville?
Compare neurologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
155
Per 100K population
15.4
County median income
$68,447
Nearest hospital
HCA FLORIDA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Groblewski is a clinical cardiology specialist, with above-average Medicare volume (top 28% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Groblewski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Groblewski performed 385 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Groblewski receive payments from pharmaceutical companies?
Yes. Dr. Groblewski received a total of $12,366 from 65 companies across 776 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Groblewski's costs compare to other neurologys in Jacksonville?
Dr. Groblewski's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Groblewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →